Stockreport

Seelos Therapeutics Announces European Medicines Agency Guidance to Design an Open-Label Pivotal Study for SLS-005 in Sanfilippo Syndrome

Seelos Therapeutics, Inc.  (SEEL) 
Last seelos therapeutics, inc. earnings: 5/21 05:12 pm Check Earnings Report
PDF NEW YORK, March 11, 2020 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapi [Read more]